Evidence map›Paper›PMID 29200987›Full record

ReviewPhytochemistry reviews : proceedings of the Phytochemical Society of Europe2017

Bufadienolides of

Joanna Kolodziejczyk-Czepas, Anna Stochmal

Open access · hybridAbstract readReview
In one paragraph

Review in Phytochemistry reviews : proceedings of the Phytochemical Society of Europe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Solvent-Dependent Efficacy ofTropical life sciences research · 2026
    Article
  4. Review
  5. Insights into the Therapeutic Use ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Perceived Changes in Anxiety Symptom Burden During Treatment withPharmaceuticals (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Pharmacological Effects of Cinobufagin.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  14. Review
  15. Plants (Basel, Switzerland) · 2023
    Article
  16. Bioactive Compounds fromLife (Basel, Switzerland) · 2023
    Review
  17. Repurposing ofFrontiers in pharmacology · 2023
    Article
  18. Article
  19. Potential ofMolecules (Basel, Switzerland) · 2022
    Review
  20. The GenusPlants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joanna Kolodziejczyk-CzepasDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.ORCID 0000-0001-8849-1067
Anna StochmalDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, Poland.
Institute of Soil Science and Plant Cultivation · PLUniversity of Łódź · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toad venom is regarded as the main source of bufadienolides; however, synthesis of these substances takes also place in a variety of other animal and plant organisms, including ethnomedicinal plants of the

Indexed as

BufadienolideCancer therapyCytotoxicityEthnomedicineKalanchoe

Identifiers

PMID29200987
PMCPMC5696496
OpenAlexW2741664430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.